首页> 美国卫生研究院文献>other >Plasma Concentrations of the Vasoactive Peptide Fragments Mid-Regional Pro-Adrenomedullin C-Terminal Pro-Endothelin 1 and Copeptin in Hemodialysis Patients: Associated Factors and Prediction of Mortality
【2h】

Plasma Concentrations of the Vasoactive Peptide Fragments Mid-Regional Pro-Adrenomedullin C-Terminal Pro-Endothelin 1 and Copeptin in Hemodialysis Patients: Associated Factors and Prediction of Mortality

机译:血液透析患者中​​血管活性肽片段的血浆浓度中区前肾上腺髓质素C末端前内皮素1和copeptin:相关因素和死亡率预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vasopressin, endothelin and adrenomedullin are vasoactive peptides that regulate vascular tone and might play a role in hypertensive diseases. Recently, laboratory assays have been developed to measure stable fragments of vasopressin, endothelin and adrenomedullin. Little is known about their diagnostic and prognostic value in hemodialysis patients. In this study, we measured the plasma concentration of copeptin, mid-regional-pro-adrenomedullin (MR-pro-ADM) and C-terminal pro-endothelin 1 (CT-pro-ET1) in stable ambulatory hemodialysis patients (n = 239) and investigated their associations with clinical factors and mortality. In all patients enrolled, the plasma concentrations of copeptin, MR-pro-ADM and CT-pro-ET1 were largely elevated with a median concentration of 132 pmol/L (interquartile range [IQR] 78–192) for copeptin, 1.26 nmol/L (IQR 1.02–1.80) for MR-pro-ADM and 149 pmol/L (IQR 121–181) for CT-pro-ET1. The plasma concentrations of all vasoactive peptide fragments correlated with time on dialysis and plasma β2-microglobulin concentration and were negatively correlated to residual diuresis. The plasma concentration of MR-pro-ADM was a strong predictor of all-cause (univariate hazard ratio for a 10-fold increase 9.94 [3.14;32], p<0.0001) and cardiovascular mortality (hazard ratio 34.87 [5.58;217], p = 0.0001) within a 3.8-year follow-up. The associations remained stable in models adjusted for dialysis specific factors and were attenuated in a full model adjusted for all prognostic factors. Plasma copeptin concentration was weakly associated with cardiovascular mortality (only in univariate analysis) and CT-pro-ET1 was not associated with mortality at all. In conclusion, vasoactive peptide fragments are elevated in hemodialysis patients because of accumulation and, most likely, increased release. Increased concentrations of MR-pro-ADM are predictive of mortality.
机译:血管加压素,内皮素和肾上腺髓质素是调节血管紧张度的血管活性肽,可能在高血压疾病中起作用。最近,已经开发了实验室测定法以测量血管加压素,内皮素和肾上腺髓质素的稳定片段。关于它们在血液透析患者中​​的诊断和预后价值知之甚少。在这项研究中,我们测量了稳定的非卧床血液透析患者中​​的肽素,中区肾上腺髓质素原(MR-pro-ADM)和C端内皮素1(CT-pro-ET1)的血浆浓度(n = 239) ),并调查了它们与临床因素和死亡率的关系。在所有入组患者中,copeptin,MR-pro-ADM和CT-pro-ET1的血浆浓度均大幅升高,其中copeptin的中位数浓度为132 pmol / L(四分位范围[IQR] 78-192),1.26 nmol / MR-pro-ADM为L(IQR 1.02-1.80),CT-pro-ET1为149 pmol / L(IQR 121-181)。所有血管活性肽片段的血浆浓度与透析时间和血浆β2-微球蛋白浓度相关,与残留利尿呈负相关。 MR-pro-ADM的血浆浓度是所有原因(单因素危险比增加10倍,9.94 [3.14; 32],p <0.0001)和心血管疾病死亡率(危险比34.87 [5.58; 217])的强力预测指标。 ,p = 0.0001),为期3.8年。在针对透析特定因素调整的模型中,关联保持稳定,而在针对所有预后因素调整的完整模型中,关联性减弱。血浆胶原蛋白浓度与心血管疾病死亡率呈弱相关性(仅在单变量分析中),而CT-pro-ET1与死亡率完全无关。总之,血液透析患者的血管活性肽片段由于积累而增加,最有可能是释放增加。 MR-pro-ADM浓度升高可预测死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号